RONDA BERTUS: Open Payments
NPI 1437100260 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,420 in 78 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $533 · 2025 $1,420
Food & beverage: $1,420
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $273 |
| Lilly USA, LLC | 11 | $190 |
| Intercept Pharmaceuticals, Inc. | 4 | $167 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $153 |
| Madrigal Pharmaceuticals | 3 | $97 |
| Aimmune Therapeutics, Inc. | 2 | $73 |
| Gilead Sciences, Inc. | 3 | $50 |
| GENZYME CORPORATION | 3 | $48 |
| Regeneron Healthcare Solutions, Inc. | 2 | $47 |
| Ipsen Biopharmaceuticals, Inc | 2 | $39 |
Products named: OCALIVA, RINVOQ, REZDIFFRA, DUPIXENT, XIFAXAN, MOUNJARO, LINZESS, VOWST.
Industry payments across OK — which companies pay providers there.
